Drug
Antacids
Antacids is a pharmaceutical drug with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_4
1
33%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution1 total trials
Phase 4Post-market surveillance
1(100.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(2)
Other(1)
Detailed Status
Completed2
unknown1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 41 (100.0%)
Trials by Status
unknown133%
completed267%
Recent Activity
0 active trials
Showing 3 of 3
unknown
Management of Esophagitis Following Repair of Esophageal Atresia
NCT03619408
completed
Evaluation of Rebound Effect After Withdrawal of Proton Pump Inhibitor in Geriatric Population
NCT03467893
completedphase_4
Nexium 40mg Once Daily vs Prevacid 30mg Twice a Day for Control of Severe GERD
NCT00295685
Clinical Trials (3)
Showing 3 of 3 trials
NCT03619408
Management of Esophagitis Following Repair of Esophageal Atresia
NCT03467893
Evaluation of Rebound Effect After Withdrawal of Proton Pump Inhibitor in Geriatric Population
NCT00295685Phase 4
Nexium 40mg Once Daily vs Prevacid 30mg Twice a Day for Control of Severe GERD
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3